Biological imaging and the molecular basis of dopaminergic diseases
- 1 August 1997
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 54 (3) , 341-348
- https://doi.org/10.1016/s0006-2952(97)00031-2
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: Behavioural, morphological and biochemical correlatesNeuroscience, 1993
- Markers of dopamine metabolism in Parkinson's diseaseNeurology, 1992
- The next frontier in Parkinson's diseaseNeurology, 1991
- Dopamine receptors and transporters in Parkinson's disease and schizophreniaThe FASEB Journal, 1990
- Mild parkinsonism in persons exposed to 1‐methyl‐4‐phenyl‐1,2,3,6‐ tetrahydropyridine (MPTP)Neurology, 1989
- Striatal dopamine deficiency in parkinson's disease: Role of agingAnnals of Neurology, 1989
- Midbrain dopaminergic cell loss in parkinson's disease: Computer visualizationAnnals of Neurology, 1989
- The role of environmental toxins in the etiology of Parkinson's diseaseTrends in Neurosciences, 1989
- Cellular and Molecular Mechanisms of Drug DependenceScience, 1988
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983